Stock overview
ACADIA Pharmaceuticals Inc.
Explore the company, reported ownership, price history, and available source evidence.
Acadia Pharmaceuticals develops and commercializes medicines for neurological disorders and rare diseases.
- Last close
- $20.68
- · ACAD
- Tracked holders
- 2 funds
- Latest available 13F per fund
ACAD · USD
Price
$20.68
+$3.27
(+18.78%)
over selected range
Close · Sep 25, 2026
Market closed
1255 stored daily closes
$20.68
Sep 25, 2026
- Range low
- $13.01
- Range high
- $33.47
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Baker Bros. Advisors largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | +0% 26'Q2 | $1,085,696,471 | 5.44% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market